Executive Summary:
Phloroglucinol (1,3,5 trihydroxybenzene) is used in the production of a plethora of applications such as explosive or propellant compounds, medicaments, cosmetics, dyes, and others which make it such a sought-after resource. However, Phloroglucinol is difficult to synthesize by chemical synthesis and alternative routes are desired. Michigan State University researchers have discovered a biosynthetic route to make Phloroglucinol from glucose, while avoiding hazardous chemical and petroleum based starting materials, in addition to doing so in a more efficient and higher yielding manner. that was found to be amenable to microbial synthesis. This method allows for cost-effective production of Phloroglucinol with higher yields and an environmentally clean route.
Description of the Technology:
The invention provides the methods, enzymes, and cells for the biosynthetic production of Phloroglucinol from malonyl-CoA, and ultimately from simple starting materials such as glucose utilizing a recombinant cell comprising phloroglucinol synthase. Specifically, the present invention provides an entirely biosynthetic, anabolic route for Phloroglucinol synthesis that does not require all four of the phlABCD operon enzymes and is capable of commercial Phloroglucinol production using only a phlD enzyme or other Phloroglucinol synthase. In addition to the pathway itself, methods for preparing derivatives of biosynthetic Phloroglucinol were also established, such as that of Resorcinol.
Benefits:
Applications:
Patent Status:
Issued patent US 7,943,362
Licensing Rights:
Full licensing rights available
References:
Journal of the American Chemical Society, 2005
Inventors:
Dr. John W. Frost
Tech Identification:
TEC2005-0021